While Keros Therapeutics Inc has underperformed by -2.65%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, KROS fell by -75.72%, with highs and lows ranging from $73.00 to $12.35, whereas the simple moving average fell by -75.18% in the last 200 days.
On December 16, 2024, Oppenheimer Reiterated Keros Therapeutics Inc (NASDAQ: KROS) to Outperform. A report published by Guggenheim on December 16, 2024, Downgraded its rating to ‘Neutral’ for KROS. H.C. Wainwright also reiterated KROS shares as ‘Buy’, quoting a target price of $47 on the company’s shares in a report dated December 13, 2024. TD Cowen December 12, 2024d its ‘Buy’ rating to ‘Hold’ for KROS, as published in its report on December 12, 2024. Jefferies also rated the stock as ‘Buy’.
Analysis of Keros Therapeutics Inc (KROS)
Further, the quarter-over-quarter increase in sales is 4750.00%, showing a positive trend in the upcoming months.
Keros Therapeutics Inc’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of -43.82% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 19.03, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can be an extremely valuable indicator of volatility, and KROS is registering an average volume of 965.29K. On a monthly basis, the volatility of the stock is set at 7.85%, whereas on a weekly basis, it is put at 7.66%, with a loss of -20.20% over the past seven days. Furthermore, long-term investors anticipate a median target price of $43.55, showing growth from the present price of $12.48, which can serve as yet another indication of whether KROS is worth investing in or should be passed over.
How Do You Analyze Keros Therapeutics Inc Shares?
Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 18.87%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 83.72% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
KROS shares are owned by institutional investors to the tune of 83.72% at present.